ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: Post-hoc analysis of a randomised controlled trial

Lim, Yuan Z.; Cicuttini, Flavia M.; Wluka, Anita E.; Jones, Graeme; Hill, Catherine L.; Forbes, Andrew B.; Tonkin, Andrew; Berezovskaya, Sofia; Tan, Lynn; Ding, Changhai; Wang, Yuanyuan*南方医科大学; 河北医科大学
Frontiers in Medicine2022-8-25DOI: 10.3389/fmed.2022.939800
1被引19阅读
引用收藏
分享

摘要

ObjectivePopulations with knee osteoarthritis (KOA) are at increased risk of cardiovascular disease, due to higher prevalence of risk factors including dyslipidaemia, where statins are commonly prescribed. However, the effect of statins on muscles and symptoms in this population is unknown. Thus, this study examined the effect of atorvastatin on muscle properties in patients with symptomatic KOA. DesignPost-hoc analysis of a 2-year multicentre randomised, double-blind, placebo-controlled trial. SettingAustralian community. ParticipantsParticipants aged 40-70 years (mean age 55.7 years, 55.6% female) with KOA who met the American College of Rheumatology clinical criteria received atorvastatin 40 mg daily (n = 151) or placebo (n = 153). Main outcome measuresLevels of creatinine kinase (CK), aspartate transaminase (AST), and alanine transaminase (ALT) at 1, 6, 12, and 24 months; muscle strength (by dynamometry) at 12 and 24 months; vastus medialis cross-sectional area (CSA) on magnetic resonance imaging at 24 months; and self-reported myalgia. ResultsThere were no significant between-group differences in CK and AST at all timespoints. The atorvastatin group had higher ALT than placebo group at 1 (median 26 vs. 21, p = 0.004) and 6 (25 vs. 22, p = 0.007) months without significant between-group differences at 12 and 24 months. Muscle strength increased in both groups at 24 months without between-group differences [mean 8.2 (95% CI 3.5, 12.9) vs. 5.9 (1.3, 10.4), p = 0.49]. Change in vastus medialis CSA at 24 months favoured the atorvastatin group [0.11 (-0.10, 0.31) vs. -0.23 (-0.43, -0.03), p = 0.02] but of uncertain clinical significance. There was a trend for more myalgia in the atorvastatin group (8/151 vs. 2/153, p = 0.06) over 2 years, mostly occurring within 6 months (7/151 vs. 1/153, p = 0.04). ConclusionsIn those with symptomatic KOA, despite a trend for more myalgia, there was no clear evidence of an adverse effect of atorvastatin on muscles, including those most relevant to knee joint health.

学科与关键词

关键词
statinsosteoarthritiskneemusclesmyalgia
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2022-08-25
卷期
第 9 卷
页码
939800
DOI
10.3389/fmed.2022.939800
期刊等级
3区
成果收录
SCIE
资助标注
National Health and Medical Research Council of Australia (NHMRC) [APP1048581]; NHMRC Clinical Postgraduate Scholarship [APP1133903]; Royal Australasian College of Physicians Woolcock Scholarship; NHMRC Investigator Grant [APP1194829]; Royal Australian College of Physicians Fellows Career Development Fellowship; NHMRC Practitioner Fellowship; NHMRC Translating Research into Practice Fellowship [APP1168185]

作者

  • L

    Lim, Yuan Z. (第一作者)

  • C

    Cicuttini, Flavia M.

查看全部 11 位作者收起作者
  • W

    Wluka, Anita E.

  • J

    Jones, Graeme

    inst med

  • H

    Hill, Catherine L.

  • F

    Forbes, Andrew B.

  • T

    Tonkin, Andrew

  • B

    Berezovskaya, Sofia

  • T

    Tan, Lynn

  • D

    Ding, Changhai

    inst med · southern med univ

  • W

    Wang, Yuanyuan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417